Back to Search
Start Over
AbbVie Submits Regulatory Applications to FDA and EMA for Risankizumab (SKYRIZI(r)) in Ulcerative Colitis
- Source :
- Plus Company Updates. August 29, 2023
- Publication Year :
- 2023
-
Abstract
- NORTH CHICAGO, Ill: AbbVie has issued the following news release: AbbVie (NYSE: ABBV) today announced that it has submitted applications for a new indication to the U.S. Food and Drug [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.763273989